Quálitas Controladora, S.A.B. de C.V. (BMV:Q)
Mexico · Delayed Price · Currency is MXN 166.26
-1.56 (-0.93%)
Aug 8, 2025, 1:59 PM CST
Inozyme Pharma Income Statement
Financials in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 65,429 | 61,293 | 49,591 | 39,969 | 36,067 | 36,779 | Upgrade |
Total Interest & Dividend Income | 3,372 | 3,388 | 3,074 | 2,195 | 1,614 | 1,509 | Upgrade |
Gain (Loss) on Sale of Investments | 1,394 | 862.98 | 585.8 | -1,111 | 284.72 | -251.47 | Upgrade |
Total Revenue | 70,195 | 65,543 | 53,251 | 41,054 | 37,966 | 38,036 | Upgrade |
Revenue Growth (YoY) | 16.98% | 23.08% | 29.71% | 8.13% | -0.18% | 4.59% | Upgrade |
Policy Benefits | 42,027 | 40,514 | 35,174 | 28,194 | 23,437 | 19,210 | Upgrade |
Policy Acquisition & Underwriting Costs | 16,409 | 15,181 | 11,933 | 9,454 | 8,846 | 7,794 | Upgrade |
Depreciation & Amortization | 531.72 | 508.02 | 527.38 | 565.88 | 482.19 | 488.72 | Upgrade |
Selling, General & Administrative | 702.3 | 246.1 | -542.04 | -124.83 | -147.03 | 320.89 | Upgrade |
Other Operating Expenses | -551.72 | -508.55 | -421.61 | -319.59 | -302.48 | -412.98 | Upgrade |
Reinsurance Income or Expense | 3.87 | 11.21 | 9.05 | 7.78 | 21 | 9.85 | Upgrade |
Total Operating Expenses | 61,380 | 57,941 | 48,232 | 38,610 | 33,277 | 28,979 | Upgrade |
Operating Income | 8,815 | 7,602 | 5,019 | 2,444 | 4,689 | 9,057 | Upgrade |
Currency Exchange Gain (Loss) | 76.61 | 101.38 | -99.17 | 6.99 | 26.93 | 44.55 | Upgrade |
Other Non Operating Income (Expenses) | 76.98 | 57.33 | 24.74 | 15.3 | 48.01 | 260.16 | Upgrade |
EBT Excluding Unusual Items | 8,968 | 7,761 | 4,945 | 2,466 | 4,764 | 9,362 | Upgrade |
Other Unusual Items | -18.9 | -18.9 | -57.68 | -11.18 | 0.07 | - | Upgrade |
Pretax Income | 8,950 | 7,742 | 4,887 | 2,455 | 4,764 | 9,362 | Upgrade |
Income Tax Expense | 2,900 | 2,623 | 1,096 | 245.47 | 986.49 | 2,564 | Upgrade |
Earnings From Continuing Ops. | 6,049 | 5,119 | 3,791 | 2,209 | 3,778 | 6,798 | Upgrade |
Minority Interest in Earnings | -27.03 | -29.17 | -15.43 | -3.95 | -3.42 | -4.47 | Upgrade |
Net Income | 6,022 | 5,090 | 3,776 | 2,205 | 3,775 | 6,794 | Upgrade |
Net Income to Common | 6,022 | 5,090 | 3,776 | 2,205 | 3,775 | 6,794 | Upgrade |
Net Income Growth | 26.81% | 34.80% | 71.21% | -41.57% | -44.44% | 26.89% | Upgrade |
Shares Outstanding (Basic) | 395 | 394 | 396 | 394 | 398 | 520 | Upgrade |
Shares Outstanding (Diluted) | 395 | 394 | 396 | 394 | 398 | 520 | Upgrade |
Shares Change (YoY) | -0.13% | -0.42% | 0.49% | -1.11% | -23.43% | 24.14% | Upgrade |
EPS (Basic) | 15.24 | 12.91 | 9.54 | 5.60 | 9.48 | 13.06 | Upgrade |
EPS (Diluted) | 15.24 | 12.91 | 9.54 | 5.60 | 9.48 | 13.06 | Upgrade |
EPS Growth | 26.97% | 35.37% | 70.38% | -40.91% | -27.44% | 2.21% | Upgrade |
Free Cash Flow | 4,685 | 2,996 | 3,632 | 3,756 | 2,923 | 1,496 | Upgrade |
Free Cash Flow Per Share | 11.86 | 7.60 | 9.18 | 9.54 | 7.34 | 2.88 | Upgrade |
Dividend Per Share | 10.000 | 10.000 | 8.000 | 5.000 | 6.500 | 4.000 | Upgrade |
Dividend Growth | 25.00% | 25.00% | 60.00% | -23.08% | 62.50% | 135.29% | Upgrade |
Operating Margin | 12.56% | 11.60% | 9.43% | 5.95% | 12.35% | 23.81% | Upgrade |
Profit Margin | 8.58% | 7.77% | 7.09% | 5.37% | 9.94% | 17.86% | Upgrade |
Free Cash Flow Margin | 6.68% | 4.57% | 6.82% | 9.15% | 7.70% | 3.93% | Upgrade |
EBITDA | 9,259 | 8,022 | 5,463 | 2,924 | 5,172 | 9,546 | Upgrade |
EBITDA Margin | 13.19% | 12.24% | 10.26% | 7.12% | 13.62% | 25.10% | Upgrade |
D&A For EBITDA | 443.68 | 419.98 | 444.1 | 480.21 | 482.19 | 488.72 | Upgrade |
EBIT | 8,815 | 7,602 | 5,019 | 2,444 | 4,689 | 9,057 | Upgrade |
EBIT Margin | 12.56% | 11.60% | 9.43% | 5.95% | 12.35% | 23.81% | Upgrade |
Effective Tax Rate | 32.41% | 33.88% | 22.42% | 10.00% | 20.71% | 27.38% | Upgrade |
Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.